Sort by
Refine Your Search
-
Category
-
Program
-
Employer
-
Field
-
complement the scientific profile of the Molecular and Integrative Biosciences Research Programme: https://www.helsinki.fi/en/faculty-biological-and-environmental-sciences/research/molecular-and-integrative
-
nine different units, to address challenges relating to the production, processing, distribution and use of food and drug products without compromising human safety, health, and cultural and social
-
Devices (QCD) group at the Department of Applied Physics. In this position you have a chance to make history by demonstrating some of the first experiments of the future quantum-computer technology that is
-
competencies. Role Requirements A Master’s or Doctoral degree preferably in psychology, cognitive science, computer science, or a related field. Meticulous work ethic and excellent time management. Prior
-
using the University of Helsinki Recruitment System by clicking the button “Apply now”. The application should include: A cover letter explaining the applicant’s motivation in joining the research program
-
forest sciences degree programs and in the university-level Liberal Arts and Sciences (LAS) program. The Department of Forest Sciences offers the LAS program "Resource management of global forests" study
-
experience during their PhD and postdoc periods. The selected group leaders are expected to initiate a new independent research program in one of FIMM’s research fields. Background FIMM is a leading molecular
-
programme development in the key areas of software engineering. The duties related to the field of research include the following: 1) high-impact international research 2) preparation of national and
-
Assistant Professor/Associate Professor or Professor in Ecological Restoration of Urban Environments
-sciences ) is Finland’s premier hub for environmental and life science research and education. The position is based in the Ecosystems and Environment Research Programme, which is one of the three Research
-
medication security are challenged by the high costs of development, manufacture and distribution, evaluation of preclinical safety and efficacy, and the dependence of drug manufacturing on international